News for hackers. Stuff that matters.
Re:FDA Warning Letter to 23andMe by Dylan16807 on Monday November 25, 2013 @03:41PM (#6796819)
I think whether it's exclusive is a very large part of the point.
Re:FDA Warning Letter to 23andMe by anigbrowl on Monday November 25, 2013 @04:20PM (#6797128)
I disagree. certainly, the risk of misdiagnosis is is inverse proportion to the degree of supplementarity, but that can still affect an awful lot of people and result in significant economic loss. It seems to me that some people want to argue this on a binary basis, ie since 23andme does not purport to replace the advice of a primary physician, its liability for misdiagnosis therefore should fall to zero. To me, though, it seems quite likely that if 23andme suggests a risk factor that is greater than the probability spread between different options offered by a patient's physician(s), then it's very likely that the 23andme data will be given excess weight given the notoriously poor grasp of Bayesian inference among the general population (and even among some groups of clinicians).

If anything, the supplementary nature of 23andme's test data should make compliance easier, since their burden will drop proportionately under the B<PL formula employed to assess tort liability in the US. http://en.wikipedia.org/wiki/Calculus_of_negligence

I wonder if you and other folks who seem to be espousing this binary approach live in or hail from states with contributory negligence regimes.